Old Web
English
Sign In
Acemap
>
authorDetail
>
Ibrahim Qazi
Ibrahim Qazi
Medicine
Antibody
Synovitis
Inflammation
Pigmented villonodular synovitis
4
Papers
50
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase I/II dose escalation and expansion study of cabiralizumab (cabira; FPA-008), an anti-CSF1R antibody, in tenosynovial giant cell tumor (TGCT, diffuse pigmented villonodular synovitis D-PVNS).
2017
Journal of Clinical Oncology
Kamalesh Kumar Sankhala
Jean-Yves Blay
Kristen N. Ganjoo
Antoine Italiano
Andrew Bassim Hassan
Tae Min Kim
Vinod Ravi
Philippe Cassier
Piotr Rutkowski
Neil Sankar
Ibrahim Qazi
Robert Sikorski
Helen Collins
Charlie Zhang
Ellyn Shocron
Hans Gelderblom
Show All
Source
Cite
Save
Citations (14)
Tenosynovial Giant Cell Tumor: Incidence, Prevalence, Patient Characteristics, and Recurrence. A Registry-based Cohort Study in Denmark
2017
The Journal of Rheumatology
Vera Ehrenstein
Søren L. Andersen
Ibrahim Qazi
Neil Sankar
Alma B Pedersen
Robert Sikorski
John F. Acquavella
Show All
Source
Cite
Save
Citations (18)
Abstract B143: A phase 1a/1b study of FPA008 in combination with nivolumab in patients with selected advanced cancers
2016
Cancer immunology research
Julie R. Brahmer
Drew W. Rasco
Minjia Chen
Emma Masteller
Ibrahim Qazi
Seema Rogers
Neil Sankar
Robert Sikorski
Julie Hambleton
F. Stephen Hodi
Show All
Source
Cite
Save
Citations (4)
The Clinical Landscape of Antibody-drug Conjugates
2014
Sohayla Rostami
Ibrahim Qazi
Robert Sikorski
Show All
Source
Cite
Save
Citations (14)
1